Live interviews

CRISPR Medicine News • 8th February 2025

Prenatal gene editing for the treatment of early onset inherited diseases

In this episode of CMN Live, CMN Editor-in-chief Karen O'Hanlon Cohrt will chat with Associate Professor Alessia Cavazza about advances in prenatal (in utero) gene editing for the treatment of early onset, rare inherited diseases.

CRISPR Medicine News • 16th November 2024

Gene-editing therapies for ultra-rare muscle diseases: approaches and challenges

In this episode of CMN Live, CMN Editor-in-chief Karen O'Hanlon Cohrt will chat with special guest Dr. Cecilia Jimenez-Mallebrera about collagen VI-related muscular dystrophies, current treatment options and prognosis, and how gene-editing technologies are being used to develop novel treatments.

CRISPR Medicine News • 27th September 2024

2024-09-27_CMN Live: CRISPR next frontier in vivo editing of the microbiome

In this episode of CMN Live, I chat with special guest Xavier Duportet (CEO, Eligo Bioscience) about the human microbiome, its role in health and disease, and how gene editing within the microbiome will open a whole new chapter in medicine.

CRISPR Medicine News • 15th March 2024

2024-03-15_CMN Live: Detecting Colorectal Cancer Using CRISPR

In this CMN Live episode, I speak with special guest Daniel Worthley MD, PhD, about the importance and challenge of detecting colorectal cancer, and the ways in which CRISPR might be part of a solution. Daniel Worthley is a cancer researcher and gastroenterologist at Colonoscopy Clinic in Queensland, Australia.

CRISPR Medicine News • 26th January 2024

2024-01-26 CMN Live: Therapeutic gene editing. A lot done, a lot more to do

In this inaugural CMN Live episode, I speak with Eric B. Kmiec of ChristianaCare Gene Editing Institute and CorriXR Therapeutics. We discuss the successes and challenges of therapeutic gene editing.